Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.

Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Abstract Text:

    ali ahmedAli Ahmed,

    BACKGROUND: Digoxin reduces hospitalizations due to heart failure (HF) and may also reduce mortality at low serum digoxin concentrations (SDC). Most HF patients are > or = 65 years, yet the effects of digoxin on outcomes in these patients have not been well studied. METHODS: Of the 7788 ambulatory chronic HF patients in normal sinus rhythm in the Digitalis Investigation Group trial (1991-1995), 5548 (2890 were > or = 65 years) were alive at 1 month and were either receiving placebo or had data on SDC. Of these patients, 982 had low (0.5-0.9 ng/mL) and 705 had high (> or = 1 ng/mL) SDC. RESULTS: Among patients > or = 65 years, compared with 38% placebo patients, 34% low SDC patients died during 39 months of median follow-up (adjusted hazard ratio [AHR] = 0.81; 95% confidence interval [CI] = 0.68-0.96; p =.017). All-cause hospitalizations occurred in 70% of placebo and 68% of low-SDC patients (AHR = 0.86; 95% CI = 0.76-0.98; p =.019). Reduction in hospitalizations for HF occurred in both low and high SDC groups. High SDC was not independently associated with all-cause hospitalization or all-cause mortality. Age, impaired renal function, and pulmonary congestion reduced the odds of low SDC. Low-dose digoxin (< or = 0.125 mg/d) was the strongest independent predictor of low SDC (adjusted odd ratio = 2.37; 95% CI = 1.65-3.39); p <.0001). CONCLUSIONS: Digoxin at low SDC was associated with a reduction in mortality and hospitalization in chronic geriatric HF, and low-dose digoxin was the strongest predictor of low SDC.

    Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Publishing Authors By Initials

    a ahmedA Ahmed,

    For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

    PUBMED ID PMID:

    MEDLINE DATE:

    Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: The journals of gerontology. Series A, Biological

    VOLUME: 62

    Page Numbers: 323-9

    Journal Abbreviation: J. Gerontol. A Biol. Sci. Med.

    ISSN: 1079-5006

    DAY: 3

    MONTH: Mar

    YEAR: 2007

    Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502837

    Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Keywords Mesh Terms:

    KEYWORDS: United States

    MESH TERMS: epidemiology

    Chemical & Substance for Abstract: Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. Information

    Substance Name: Creatinine

    Registry Number: 60-27-5

    Grant and Affiliation Information for Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.

    AFFILIATION: Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham AL 35294-2041, USA. aahmed@uab.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: P50 HL077100

    ACRONYM: HL

    MEDLINETA: J Gerontol A Biol Sci Med Sci

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News